ALBANY MOLECULAR RESEARCH HRC PVT LTD PLOT NO 9. MN PARK TURKAPALLY V. HYDERABAD 500 078 TS INDIA

Location: PLOT NO 9. MN PARK TURKAPALLY V. HYDERABAD 500 078 TS INDIA

Company Overview:

ALBANY MOLECULAR RESEARCH HRC PVT LTD was a subsidiary of Albany Molecular Research Inc. (AMRI), a global contract research and manufacturing organization (CRAMO). AMRI was acquired by Curia in 2021, and its operations now fall under the Curia umbrella. The Hyderabad facility is a significant site primarily focused on providing comprehensive research, development, and manufacturing services to the pharmaceutical and biotechnology industries. Its services typically span drug discovery, process development, and the production of active pharmaceutical ingredients (APIs) and advanced intermediates. It plays a crucial role in supporting clients through various stages of drug development, from early-stage research to commercial supply.

Business Type:

This company operates as a manufacturer and a research and development facility. It is not a trading company.

ALBANY MOLECULAR RESEARCH HRC PVT LTD, now operating as Curia, is a contract research, development, and manufacturing organization (CDMO) that provides services to pharmaceutical and biotechnology companies. The company produces or sells a range of services and outputs including: medicinal chemistry services, in vitro biology services, ADME DMPK services, lead optimization services, process research and development, analytical development and quality control services, cGMP manufacturing of Active Pharmaceutical Ingredients (APIs), formulation development, and drug product manufacturing such as oral solids and sterile injectables. They also offer bioprocess development, mammalian cell line development, and biologics manufacturing services. Their work involves the custom synthesis of chemical compounds, drug intermediates, and active pharmaceutical ingredients manufactured on behalf of client companies.